Literature DB >> 8098977

Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2.

E Gardner1, L Papi, D F Easton, T Cummings, C E Jackson, M Kaplan, D R Love, S E Mole, J K Moore, L M Mulligan.   

Abstract

We have carried out genetic linkage analyses using fifteen polymorphic loci in the pericentromeric region of chromosome 10 in families with the inherited cancer syndromes multiple endocrine neoplasia (MEN) type 2A or 2B. A highly polymorphic microsatellite from the locus D10S141 in q11.2 was found to be recombinant with respect to the disease locus in two individuals and defines a new proximal flanking marker for both MEN2A and 2B. An additional recombination provides evidence that the locus D10S94, also in q11.2, is the closet distal flanking marker for MEN2A. This localises the MEN2A gene to a small region of 10q11.2 flanked by the loci D10S141 and D10S94, which are separated by a sex-averaged genetic distance of 0.55 cM. The MEN2B gene maps to a larger region, flanked by D10S141 and RBP3.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098977     DOI: 10.1093/hmg/2.3.241

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  11 in total

Review 1.  Multiple endocrine neoplasia type 2 and the practice of molecular medicine.

Authors:  C Eng
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 3.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

4.  A multiple interval physical map of the pericentromeric region of human chromosome 10.

Authors:  A Tunnacliffe; M S Jackson; E Gardner; D R Love; J K Moore; S E Mole; L M Mulligan; A Graham; G Finocchiaro; S Orstavik
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

5.  Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.

Authors:  Paul Komminoth; Seraina Muletta-Feurer; Parvin Saremaslani; Eva K. Kunz; Xavier Matias-Guiu; Olaf Hiort; Soren Schroder; Walter K. F. Seelentag; Jurgen Roth; Philipp U. Heitz
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

6.  Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Authors:  A Frilling; W Höppner; C Eng; L Mulligan; F Raue; C E Broelsch
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

7.  Medullary thyroid cancer: molecular factors, management and treatment.

Authors:  Efstathios Pavlidis; Konstantinos Sapalidis; Fotios Chatzinikolaou; Isaak Kesisoglou
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

8.  Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies.

Authors:  Karen Gómez; Jeena Varghese; Camilo Jiménez
Journal:  J Thyroid Res       Date:  2011-05-16

9.  Spontaneous adrenal pheochromocytoma rupture complicated by intraperitoneal hemorrhage and shock.

Authors:  Joseph S Hanna; Philip J Spencer; Cornelia Savopoulou; Edward Kwasnik; Reza Askari
Journal:  World J Emerg Surg       Date:  2011-08-15       Impact factor: 5.469

10.  Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Authors:  Makito Suzuki; Hideki Makinoshima; Shingo Matsumoto; Ayako Suzuki; Sachiyo Mimaki; Koutatsu Matsushima; Kiyotaka Yoh; Koichi Goto; Yutaka Suzuki; Genichiro Ishii; Atsushi Ochiai; Koji Tsuta; Tatsuhiro Shibata; Takashi Kohno; Hiroyasu Esumi; Katsuya Tsuchihara
Journal:  Cancer Sci       Date:  2013-05-12       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.